Hims & Hers Health, Inc. (HIMS) May weekly option implied volatility into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Hims and Hers (HIMS) PT Lowered to $14 at Jefferies
May 7, 2024 4:03 PM EDTJefferies analyst Glen Santangelo lowered the price target on Hims and Hers (NYSE: HIMS) to $14.00 (from $15.00) while maintaining a Hold rating.
The analyst comments "We are updating our model following 1Q results. The updated model reflects the company's impressive profitability ramp... More
Hims and Hers (HIMS) PT Raised to $16 at Deutsche Bank
May 7, 2024 5:24 AM EDTDeutsche Bank analyst George Hill raised the price target on Hims and Hers (NYSE: HIMS) to $16.00 (from $14.00) while maintaining a Hold rating.
The analyst comments "Based on the strong momentum in Q1, management raised the 2024 revenue guidance by $30 million at the... More
